GILD vs MG · P/E 18, rev $29.44B vs P/E 18, rev $729.6M
Gilead Sciences Inc (GILD) versus Mistras Group Inc (MG) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Mistras Group Inc (MG) is a security & protection services company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MG revenue for 2024-12-31 was $729.6M. Net income was $19.0M. Revenue was up 300.7% from 2023-12-31 to 2024-12-31. MG currently screens at market cap $258.5M and trailing P/E 17.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MG currently screens at market cap $258.5M and trailing P/E 17.7.
Not investment advice. Open the GILD and MG stock pages for the full models.
Not investment advice.